Cizzle Biotechnology (CIZ)

[ADVERT]
Company name:Cizzle Biotechnology Holdings Plc
EPIC:CIZTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BNG2VN02
Market Segment:SSQ3Share Type:DE
WWW Address:http://bouldopportunities.com/Description:ORD 0.01P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 5.00 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 4.80 5.20 5.00 5.00 5.00 -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 12.67 253.45 - - - - - 11.50 - 4.75

Cizzle Biotechnology Key Figures

(at previous day's close)
Market Cap.12.67m
Shares In Issue253.45m
Prev. Close5.00
PE Ratio- 
Dividend Yield-%
EPS - basic-p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.12p
Return On Equity (ROE)-956.25%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt-0.03m
Gross Gearing64.44%
Quick Assets0.09m
Net Working Capital0.03m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-0.12p
Retained Profit PS-0.12p
Cash PS0.03p
Net Cash PS0.01p
Net Tangible Asset Value PS *0.01p
Net Asset Value PS0.01p
Spread0.40 (7.69%) 

Cizzle Biotechnology Balance Sheet

L^CIZ:Liabilities+EQL^CIZ:Assets

Share Price Performance

Sample Period HighLow
1 week5.255.00
4 weeks6.254.75
12 weeks11.504.75
1 year11.504.75

Share Price Chart (5 years)

Cizzle Biotechnology Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week5.25-0.25-4.765.001.035.24
4 weeks5.25-0.25-4.764.750.555.35
12 weeks11.50-6.50-56.524.751.076.78
26 weeks11.50-6.50-56.524.751.076.78
1 year11.50-6.50-56.524.751.076.78
3 years11.50-6.50-56.524.751.076.78
5 years11.50-6.50-56.524.751.076.78

Cizzle Biotechnology Key Management Ratios

Cizzle Biotechnology Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 140.80 
Tobin's Q Ratio (excl. intangibles)140.80 
Dividend Yield-%
Market-to-Book Ratio396.01 
Price-to-Pre-Tax Profit PS-41.41 
Price-to-Retained Profit PS-41.41 
Price-to-Cash Flow PS-43.10 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS396.01 
Price-to-Cash PS150.86 
Net Working Capital PS0.01 
Price Pct to Working Capital PS396.01%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Cizzle Biotechnology Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-28.89%
Net Gearing (excl. Intangibles)-28.89%
Gross Gearing64.44%
Gross Gearing (excl. Intangibles)64.44%
Gearing Under 1 Year64.44%
Gearing Under 1 Year (excl. Intgbl)64.44%
Assets/Equity2.81 
Cash/Equity262.50 
(Liquidity Ratios)
Net Working Capital to Total Assets35.56%
Current Ratio1.55 
Quick Ratio (Acid Test)1.55 
Liquidity Ratio1.45 
Cash & Equiv/Current Assets93.33%
(Solvency Ratios)
Enterprise Value12.59m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-3.27 
CFO/Debt-5.07 
Total Debt/Equity Market Value0.00 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.19 
Total Debt0.06m
Total Debt/Net Current Assets1.81%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
Sorry No Data AvailableSorry No Data Available

Cizzle Biotechnology Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-956.25%
Return On Assets (ROA)-340.00%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-956.25%
Return On Investment (ROI)-956.25%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Cizzle Biotechnology Dividends

Sorry No Data Available

Cizzle Biotechnology Fundamentals

 31 Dec 2020 (GBP)
turnover--m
pre tax profit-0.31-m
attributable profit-0.31-m
retained profit-0.31-m
eps - basic (p)- 
eps - diluted (p)- 
dividends per share- 

Cizzle Biotechnology Balance Sheet

 31 Dec 2020 (GBP)
L^CIZ:Liabilities+EQL^CIZ:Assets
 31 Dec 2020 (GBP)
ASSETS
fixed assets fixed assets--m
intangibles intangibles--m
fixed investments fixed investments--m
current assets - other current assets - other--m
stocks stocks--m
debtors debtors0.01-m
cash & securities cash & securities0.08-m
TOTAL0.09100%m
LIABILITIES
creditors - short creditors - short0.06-m
creditors - long creditors - long--m
creditors - other creditors - other--m
subordinated loans subordinated loans--m
insurance funds insurance funds--m
TOTAL0.06-m
EQUITY
ord cap, reserves ord cap, reserves0.03-m
prefs, minorities prefs, minorities--m
TOTAL0.03-m
OTHER
NAV Basic- 
NAV Diluted- 

Cizzle Biotechnology Cash Flow Statement

31 Dec 2020 (GBP)
Operating CF-0.29m
Pre-Financing CF-0.29m
Retained CF-0.29m

Cizzle Biotechnology Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
CIZ
Cizzle Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 12:38:02